Seeing Is Believing

Currently out of the existing stock ratings of Matthew Sheerin, 149 are a BUY (54.18%), 126 are a HOLD (45.82%).
Analyst Matthew Sheerin, carries an average stock price target met ratio of 89.4% that have a potential upside of 21.51% achieved within 276 days. Previously, Matthew Sheerin worked at NEEDHAM, STIFEL.
Matthew Sheerin’s has documented 540 price targets and ratings displayed on 25 stocks. The coverage was on Technology, Healthcare sectors.
Most recent stock forecast was given on PRVA, Privia Health Group at 10-Apr-2025.
Analyst best performing recommendations are on CLS (CELESTICA).
The best stock recommendation documented was for SONO (SONOS) at 8/27/2018. The price target of $20 was fulfilled within 1 day with a profit of $1.08 (5.71%) receiving and performance score of 57.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-May-2026
$250
$22.1 (9.70%)
$260
2 months 8 days ago
(07-Aug-2026)
22/25 (88%)
$46.49 (22.84%)
135
Sell Since 03-Feb-2023
$200
$-27.9 (-12.24%)
$175
2 months 8 days ago
(07-Aug-2026)
8/13 (61.54%)
$-3.51 (-1.72%)
312
Sell Since 09-Jun-2025
$233
$5.1 (2.24%)
$110
5 months 2 days ago
(13-May-2026)
10/10 (100%)
$21.18 (10.00%)
294
Buy Since 03-Feb-2022
$135
$-80.15 (-37.25%)
$140
1 years 11 months 14 days ago
(01-Nov-2024)
5/5 (100%)
$13.97 (11.54%)
733
Hold Since 14-Dec-2020
$132
$-83.15 (-38.65%)
$132
2 years 4 months 17 days ago
(28-May-2024)
8/8 (100%)
$1.78 (1.37%)
71